Bioinformatic and experimental analyses identify GPR84 as a pro-tumorigenic macrophage-associated marker in glioblastoma
Background Tumor-associated macrophages are major contributors to the immunosuppressive microenvironment of glioblastoma (GBM), yet the upstream regulators of their pro-tumorigenic activity remain incompletely defined. Methods Bioinformatic analyses were combined with pharmacological experiments in RAW264.7 macrophages, conditioned-medium assays in GL261 cells, RNA sequencing, protein validation, and an orthotopic glioma model. Results Integrated pan-cancer analyses identified GPR84 as a prognostically adverse gene associated with an inflammatory and macrophage-enriched microenvironment in GBM. In RAW264.7 macrophages, pharmacological GPR84 activation with 6-OAU induced a mixed M2-like immunoregulatory phenotype characterized by increased STAT3 phosphorylation, CD206, TGF-β1, and extracellular IL-10 without altering total STAT3. Stattic partially attenuated STAT3 phosphorylation and CD206 induction, supporting a contributory but incomplete role for STAT3. Conditioned medium from 6-OAU-treated macrophages enhanced GL261 clonogenicity, migration, and invasion. RNA sequencing and protein validation further implicated ECM-receptor interaction and mesenchymal programming in recipient glioma cells. In an orthotopic model, implantation of GL261 cells preconditioned with medium from pharmacologically GPR84-activated macrophages resulted in increased tumor growth and shorter survival in recipient mice. Conclusion These findings support a pharmacological GPR84-STAT3 signaling model in macrophages and identify GPR84 as a candidate pathway for further investigation in glioblastoma.
Authors
- XianZhen Chen
- Zhouqi Qian (ORCID: https://orcid.org/0009-0006-2163-408X)
- Ran Mo (ORCID: https://orcid.org/0000-0003-4010-8879)
- Zhen Yu (ORCID: https://orcid.org/0000-0001-7950-8285)
- Shuyi Lin (ORCID: https://orcid.org/0009-0007-2333-247X)
- Da Tan
- Qingyue Yuan
- Yuan Zhuang
Institutions
- Tongji University (CN)
- Wenzhou Medical University (CN)
- Shanghai Tenth People's Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3389/fimmu.2026.1930625
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00